1,820 Shares in Humana Inc. (NYSE:HUM) Purchased by Woodline Partners LP

Woodline Partners LP acquired a new position in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,820 shares of the insurance provider's stock, valued at approximately $462,000.

A number of other institutional investors also recently made changes to their positions in HUM. Avior Wealth Management LLC increased its stake in Humana by 19.6% in the 4th quarter. Avior Wealth Management LLC now owns 335 shares of the insurance provider's stock worth $85,000 after purchasing an additional 55 shares during the period. Exchange Traded Concepts LLC increased its stake in shares of Humana by 8.5% in the fourth quarter. Exchange Traded Concepts LLC now owns 1,191 shares of the insurance provider's stock worth $302,000 after buying an additional 93 shares during the period. Blue Trust Inc. raised its holdings in Humana by 15.3% during the 4th quarter. Blue Trust Inc. now owns 1,692 shares of the insurance provider's stock valued at $429,000 after buying an additional 224 shares during the last quarter. KBC Group NV boosted its position in Humana by 26.0% during the 4th quarter. KBC Group NV now owns 48,685 shares of the insurance provider's stock valued at $12,352,000 after buying an additional 10,039 shares during the period. Finally, Pacer Advisors Inc. boosted its position in Humana by 58.5% during the 4th quarter. Pacer Advisors Inc. now owns 15,579 shares of the insurance provider's stock valued at $3,953,000 after buying an additional 5,750 shares during the period. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on HUM. Raymond James upgraded shares of Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective on the stock in a research report on Thursday, May 1st. Oppenheimer upped their price target on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Barclays lifted their price objective on Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research report on Friday, April 11th. Truist Financial dropped their price target on Humana from $325.00 to $305.00 and set a "hold" rating for the company in a research note on Monday, May 12th. Finally, Robert W. Baird boosted their price objective on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research report on Tuesday, April 15th. Seventeen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $286.81.

Humana Stock Up 1.2%

HUM stock traded up $2.83 during midday trading on Friday, hitting $232.91. The company's stock had a trading volume of 2,524,287 shares, compared to its average volume of 1,779,823. The firm's 50-day moving average is $257.92 and its 200-day moving average is $267.13. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 12 month low of $212.45 and a 12 month high of $406.46. The company has a market cap of $28.11 billion, a PE ratio of 23.41, a P/E/G ratio of 2.05 and a beta of 0.49.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. The firm had revenue of $32.11 billion for the quarter, compared to the consensus estimate of $32 billion. Humana had a return on equity of 11.70% and a net margin of 1.02%. The company's quarterly revenue was up 8.4% on a year-over-year basis. During the same period in the prior year, the company posted $7.23 earnings per share. On average, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.52%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is currently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.